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ABSTRACT 
 
Toxoplasma gondii is an obligate intracellular protozoon, spread world-wide and ca-
pable of infecting birds and mammals. Genetic information on T. gondii type that 
causes human toxoplasmosis is limited. In this study, genetic analysis of SAG2 locus 
was used to determine the genotype of T. gondii from cases with cerebral and ocular 
toxoplasmosis in Indonesia. Genotype determination was done directly on the clinical 
samples. A number of 28 cerebrospinal fluid and 8 vitreous humor positively infected 
with T. gondii, underwent PCR-RFLP to classify each isolate into one of three geno-
types of T. gondii. Type I was the most common found suggesting that cerebral and 
ocular toxoplasmosis in Indonesia is mostly caused by type I strain of T. gondii. 
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Introduction 
Toxoplasma gondii is an obligate intracellular 
protozoan of phylum Apicomplexa infecting birds 
and mammals. It is estimated that almost one-third 
of global population is infected with T. gondii [1, 
2]. Clinical manifestation of toxoplasmosis varies 
and influenced by several factors, such as duration 
of exposure, geographic, parasite genetics, im-
mune status of the host, and time of infection [3]. 
In immunocompetent individuals, Toxoplasma in-
fection only shows minor symptoms or even 
asymptomatic. On the other hand, if the infection 
occurs in immunodeficient individuals, clinical 
manifestation might be fatal or even lethal [2, 4]. 
Information on dynamics of toxoplasmosis 
cases, either continuously or periodically, is still 
limited and very few study reports on T. gondii 
genotype infecting human, hence T. gondii type is 
related to its pathogenic and biological character 
which is considered to play role in the pathogene-
sis and management of toxoplasmosis [5].  
Toxoplasma encephalitis (TE) is one of the 
most common neurological infection in AIDS pa-
tients. It causes significant morbidity and mortal-
ity [6]. Besides TE, T. gondii is one of the most 
common cause of retinochoroiditis both in immu-
nocompetent and immunocompromised individu-
als [7]. Variation in biological characteristics of 
each T. gondii type is considered to cause different 
clinical manifestations in human. 
Virulence of T. gondii in animals varies, de-
pending on the type [5]. More than 95% type of T. 
gondii isolated from North America and Europe 
belongs to one of three lineages, which referred to 
type I-III (Howe and Sibley, 1995). Genetically, 
the difference amongst each type is only 1 – 2%, 
but virulence differs significantly [2]. 
Determination of three lineages by Howe and 
Sibley in 1995 was based on analysis of six single-
copy independent locus, one of which was surface 
antigen 2 (SAG 2) which is abundantly present on 
the parasite surface [8]. Other single gen target to 
determine T. gondii genotype is GRA 6 [9]. This 
study reports the type of T. gondii among Indone-
sian patients with cerebral and ocular toxoplasmo-
sis. 
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Material and Methods 
Study sample 
Samples consisted of 88 cerebrospinal fluid 
from AIDS patients with cerebral disorder, as part 
of neuroaids study. While the 64 vitreous humor, 
obtained from patients clinically diagnosed as 
atypical uveitis and has been screened for Toxo-
plasma infection. All samples were stored in -
30oC in Parasitology Laboratory, Faculty of Med-
icine, Universitas Indonesia. The study was ap-
proved by the ethical committee of Faculty of 
Medicine, Universitas Indonesia number 721/UN 
2.F1/ETIK/2016. 
 
DNA isolation 
DNA extraction was done by boiling the sam-
ples for 10 minutes at 100oC [11]. For cerebral 
fluid, it was preceded by centrifugation of 1 mL of 
samples for 10 minutes at 10,000 rpm and leaving 
150 µL sediment for boiling. For vitreous humor, 
samples were directly boiled due to very limited 
volume of samples obtained (≤ 100 µL). 
Detection of T. gondii by PCR 
To confirm T. gondii infection in cerebrospi-
nal fluid and vitreous humor, nested PCR were 
performed targeting B1 gene, following the proce-
dure by Alfonso et al. (2008) [11]. 
 
Target DNA amplification for genotyping 
Strain type of T. gondii was determined by 
PCR-Restriction Fragment Length Polymorphism 
(RFLP) of SAG2 gene with PCR cycle condition 
in accordance to the protocol used by Fuentes et 
al. (2001), Howe et al. (1997) [4, 10]. The PCR 
was optimized and run in 20 µL reaction using 
TopTaq Polymerase Master Mix Kit (Qiagen, 
GmbH, cat no. 200403) and 2 µL DNA template 
on MJ Research PTC 200 thermocycler. The pri-
mers used are presented in the Table 1. Negative 
control (pure water) and positive control (T. gondii 
RH strain, generous gift from Indonesian Research 
Centre for Veterinary Science) were always in-
cluded in every PCR. 
Optimum nested PCR condition for 5’-SAG2  
 
Figure 1.  Genotype determination based on RFLP analysis of SAG2 gene; A) Schematic drawing of SAG2 
gene; B) Sau3AI enzyme cuts allele III sequence. B) HhaI enzyme cuts allele II sequence [10]. 
 
Table 1. Primer sequences used [4, 12] 
Target genes Forward Reverse Amplicons 
5’-SAG2 nest 1(SAG2.F4): 
GCTACCTCGAACAGGAACAC 
nest 2 (SAG2.F) 
GAAATGTTTCAGGTTGCTGC 
nest 1(SAG2.R4): 
GCATCAACAGTCTTCGTTGC 
nest 2 (SAG2.R2): 
GCAAGAGCGAACTTGAACAC 
241 bp 
3’-SAG2 nest 1(SAG2.F3): 
TCTGTTCTCCGAAGTGACTCC 
nest 2 (SAG2.F2): 
ATTCTCATGCCTCCGCTTC 
nest 1 (SAG2.R3): 
TCAAAGCGTGCA TTATCGC 
nest 2 (SAG2.R): 
AACGTTTCACGAAGG CACAC 
221 bp 
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and 3’-SAG2 genes is presented in Table 2. The 
last cycle was extended for 10 minutes at 72°C. 
The 241 bp and 221 bp of 5’-SAG2 and 3’-SAG2 
respectively PCR products were visualized on 2% 
agarose gel electrophoresis. 
The PCR products of 3’-SAG2 was digested 
with Hhal restriction enzymes by 4 hours incuba-
tion at 37°C, followed by inactivation at 65oC for 
20 minutes while 5’-SAG2 PCR product was di-
gested with Sau3AI, incubated at 37°C for 3 hours 
and inactivated at 80°C for 20 minutes. The reac-
tion was performed in 15 µL volume. The result 
was analyzed by electrophoresis on 2% agarose 
gel with TBE buffer solution and visualized by ex-
posure to UV light. GeneRuler 50-bp DNA Ladder 
(Thermo Scientific) was used as molecular size 
marker. Interpretation of the result to identify the 
T. gondii type I/II/III. 
 
Results and Discussion 
The PCR examination of B1 gene revealed 28 
out of 88 (31.82%) cerebrospinal fluid samples 
and 8 out of 64 (12.5%) ocular fluid were positive 
for T. gondii infection. PCR of the 28 spinal fluid 
previously B1 gene positive, showed fewer posi-
tive result which were 26/28 and 4/28 samples res-
pectively on 5'-SAG2 and 3'-SAG2. Similar result 
was obtained for the 8 ocular fluid samples, which 
were 100% positive on the 5'-SAG2 PCR however 
only 2/8 samples were positive on 3'-SAG2 gene. 
RFLP of gene SAG2 PCR products 
The size of amplicon for 5’-end was 241 bp 
and for 3’-end was 221 bp. PCR products were 
then digested by endonuclease restriction enzyme, 
HhaI to digest 3’-end and Sau3AI to digest 5’-end. 
Genotype analysis results by RFLP shown in Ta-
ble 3. 
Until recently, there is no report of human T. 
gondii genotypes in Indonesia and whether certain 
genotype is related to certain clinical manifesta-
tion is still a debate. Several methods can be used 
to investigate T. gondii types, from isoenzyme 
electrophoresis, restriction fragment length poly-
morphism (RFLP), multiplex PCR, DNA micro-
satellite analysis, and DNA sequencing [5, 13, 14, 
15]. Of all above, PCR-RFLP is the most common 
method used in more than 1,000 isolates in the 
world and had produced significant data on T. 
gondii genetic variation [16]. 
This work is part of a study on neuroaids 
where Toxoplasma laboratory screening has been  
Table 2. PCR condition for 5’-SAG2 and 3’-SAG2 
No Condition 5’-SAG2 3’-SAG2 
1. Denaturation  Nested I & II: 94oC, 5 minutes Nested I & II: 94oC, 5 minutes 
2. Annealing  nested I: 60oC, 45 seconds nested II: 
58oC, 45 seconds 
nested I: 58oC, 45 seconds; nested II: 
55oC, 45 seconds 
3. Elongation  Nested I & II: 72 oC, 1 minutes Nested I & II: 72 oC, 1 minutes 
4. Cycle number 40 40 
 
 
Figure 2. Work flow of T. gondii PCR of B1, 5'-SAG2 and 3'-SAG2 genes on cerebrospinal and ocular fluids 
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Table 3.  Genotyping of T. gondii from spinal and oc-
ular fluid 
Samples Type I 
(%) 
Type I or 
II (%) 
Type 
III 
(%) 
Total 
(%) 
CSF 4 
(15.38%) 
22 
(84.62%) 
0 
(0%) 
26 
(100%) 
Ocular 
fluid 
2 
 (25%) 
6 
 (75%) 
0 
(0%) 
8 
(100%) 
 
performed by PCR on B1 gene, resulted in 28/88 
(31.82%) cerebrospinal fluid samples and 8/64 
(12.5%) of aqueous humor were positive for T. 
gondii.  The incidence of active cerebral toxoplas-
mosis in our study is higher than ocular toxoplas-
mosis, as well as to similar study on HIV infected 
patients in Malaysia, which was 11.3% [17]. 
Studies about prevalence of ocular toxoplas-
mosis in Asia showed various results. In India, the 
incidence varied from 1.7 – 12%, while in Japan, 
T. gondii is only responsible for 1.1% of uveitis 
cases; 8.7% of uveitis cases in Thailand were 
caused by T. gondii [18]. Mahalakshmi et al. 
(2010) also reported that B1 gene is generally 
more sensitive to detect T. gondii DNA compared 
to SAG2, though SAG2 is able to rapidly disti-
nguish T. gondii genotype as it has polymorphic 
sites specific for each type [19]. 
Studies on genetic analysis of T. gondii, re-
ported that amplification of SAG2 required only 
small amount of DNA sample, which make it pos-
sible to be applied directly on clinical samples [4]; 
thus, important information about various T. 
gondii strain from patients suspected from clinical 
toxoplasmosis can be analyzed [10]. The Surface 
Antigen Gene 2 (SAG2) codes T. gondii P22 pro-
tein, the main surface protein showing good anti-
genicity and immunogenicity characteristic. It is 
suitable for rapid genotyping because it has spe-
cific polymorphism for each type of T. gondii [19]. 
Our study showed that amplification of 5’-
SAG2 gene of T. gondii was very good, resulted 
in 92.8% of 28 cerebrospinal fluid and 100% of 8 
aqueous / vitreous humor were positive. The good 
result on 5'-SAG2 gene was not replicable for PCR 
of 3'-SAG2, which gave positive result in only 
14.3% of 28 spinal fluids and 25% of 8 samples 
aqueous/vitreous humor previously positive on B1 
screening. The failure to amplify locus SAG2 
might be caused by the small amount of parasite in 
the samples [10]. The presence of polymorphism 
in primer attachment site of the studied isolates is 
also possible [20]. 
Amplicons of SAG2 gene, both 5' and 3'ends 
were then subjected to RFLP to reveal the geno-
type based on digestion by Sau3AI and HhaI 
restriction enzymes. Sau3AI recognize restriction 
site on T. gondii type III, whereas HhaI enzyme 
can recognize restriction site on T. gondii type II. 
Samples which are not digested by both enzymes 
suggested the type I [10].  
Genotyping by PCR-RFLP on cerebrospinal 
fluid samples could only be accomplished in 4 
samples which were successfully amplified the 5'- 
and 3’ SAG2 genes, resulted as type I  T. gondii 
(figure 3). The rest 22 spinal fluids which were 
PCR positive merely on 5'-SAG2, the RFLP could 
distinguish between type III and non-type III (I/II), 
resulted all to be non type III. No type III was 
found in the spinal fluid samples.  
As genotyping of T. gondii from aqueous/vit-
reous humor could only be performed on 2 
samples which completely amplified both SAG2 
genes, resulted in type I. The rest 6 samples which  
only amplified 5'-SAG2 were found to be either 
type I or II strain. None of the aqueous/vitreous 
humor samples was of type III strain.  
Various studies reported that type I was the 
most pathogenic strain in immunocompromised 
patients. A study in Brazil showed 46% patients 
were found to be infected by type I strain [6]. 
Similar results were also reported by Khan et al. 
(2005), among 11 samples obtained from HIV in-
fected patients and diagnosed as Toxoplasma en-
cephalitis, were infected by type I T. gondii [15]. 
Identification of T. gondii type in aqueous/vit-
reous humor in this study showed similar result as 
with the spinal fluids i.e. Type I or type II strains 
of T. gondii. This result is supported by prior study 
result in Brazil which found only type I strain in 
all 11 ocular samples positive for T. gondii [21]. 
There were also three other reports documenting 
isolation of T. gondii from immunocompetent 
adults with ocular toxoplasmosis. Two of the iso-
lation, which were performed in mice were viru-
lent towards mice, so it is likely type I, or at least 
not type II Nor type III, suggesting that type I 
strain is the most related to ocular toxoplasmosis 
in immunocompetent adults [7]. 
Nevertheless, the data above are contradictive 
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with the notion that type II is the most related to 
toxoplasmosis [22]. It is likely to be caused by 
limitation in sample analysis which used only one 
gene target to determine the parasite genotype, and 
it is strongly suggested that the strain which causes 
lesion in brain or eye is a mixed infection or be-
cause the genetic difference amongst strain is in-
deed very little [21]. Genetically, the difference 
amongst each type is only 1 – 2%, but the viru-
lence differs significantly [2]. SAG2 gene is useful 
in distinguishing type I, II, and III, but in this 
study, we did not find atypical strain as it is com-
monly found in Southern America [6]. Besides, 
characterization of genotype with gene SAG2 can 
be performed directly in clinical samples, thus it 
prevents bias in prevalence of certain type contrib-
uted by duplications of certain type in culture pro-
cess [20]. 
Other aspect to be noted in direct genotyping 
is the failure in amplification of some samples us-
ing standard protocol as described by Howe et al 
(1997) [10]. It could be due to the presence of pol-
ymorphism in primer attachment sites among the 
Indonesian isolates, which are different geograph-
ically compared to other countries isolates [20].  
 
Conclusion 
Type I and likely type II are the most common 
strain found in T. gondii infection of brain and eye. 
This study is the first research on genotyping of T. 
gondii in Indonesia. A genotyping method with 
higher resolution is needed to understand the ef-
fect of various genetic background amongst T. 
gondii strain with clinical manifestation and trans-
mission pattern in Indonesia. 
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